Annual CFI
$27.29 M
+$3.30 M+13.75%
31 December 2023
Summary:
Galera Therapeutics annual cash flow from investing activities is currently $27.29 million, with the most recent change of +$3.30 million (+13.75%) on 31 December 2023. During the last 3 years, it has fallen by -$9.25 million (-25.32%). GRTX annual CFI is now -25.32% below its all-time high of $36.55 million, reached on 31 December 2020.GRTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 June 2024
Summary:
Galera Therapeutics quarterly cash flow from investing activities is currently $0.00, unchanged on 30 June 2024. Over the past year, it has dropped by -$10.46 million (-100.00%). GRTX quarterly CFI is now -100.00% below its all-time high of $19.65 million, reached on 31 December 2021.GRTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$14.44 M
-$7.55 M-34.33%
30 June 2024
Summary:
Galera Therapeutics TTM cash flow from investing activities is currently $14.44 million, with the most recent change of -$7.55 million (-34.33%) on 30 June 2024. Over the past year, it has dropped by -$11.66 million (-44.67%). GRTX TTM CFI is now -75.89% below its all-time high of $59.90 million, reached on 30 June 2021.GRTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.8% | -100.0% | -44.7% |
| 3 y3 years | -25.3% | +100.0% | +490.6% |
| 5 y5 years | +146.2% | -100.0% | +3.4% |
GRTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -25.3% | +421.1% | -100.0% | +100.0% | -64.7% | +313.0% |
| 5 y | 5 years | -25.3% | +146.2% | -100.0% | +100.0% | -75.9% | +141.5% |
| alltime | all time | -25.3% | +146.2% | -100.0% | +100.0% | -75.9% | +141.5% |
Galera Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $0.00(0.0%) | $14.44 M(-34.3%) |
| Mar 2024 | - | $0.00(-100.0%) | $21.99 M(-19.4%) |
| Dec 2023 | $27.29 M(+13.7%) | $3.98 M(-62.0%) | $27.29 M(+4.6%) |
| Sept 2023 | - | $10.46 M(+38.6%) | $26.10 M(+29.0%) |
| June 2023 | - | $7.55 M(+42.3%) | $20.24 M(+4.8%) |
| Mar 2023 | - | $5.30 M(+90.9%) | $19.30 M(-19.6%) |
| Dec 2022 | $23.99 M(+358.1%) | $2.78 M(-39.6%) | $23.99 M(-41.3%) |
| Sept 2022 | - | $4.60 M(-30.4%) | $40.87 M(-702.8%) |
| June 2022 | - | $6.62 M(-33.8%) | -$6.78 M(-388.3%) |
| Mar 2022 | - | $10.00 M(-49.1%) | $2.35 M(-55.1%) |
| Dec 2021 | $5.24 M | $19.65 M(-145.7%) | $5.24 M(+114.2%) |
| Sept 2021 | - | -$43.04 M(-373.4%) | $2.44 M(-95.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $15.74 M(+22.2%) | $59.90 M(+11.3%) |
| Mar 2021 | - | $12.88 M(-23.6%) | $53.83 M(+47.3%) |
| Dec 2020 | $36.55 M(-231.3%) | $16.86 M(+17.0%) | $36.55 M(-265.4%) |
| Sept 2020 | - | $14.41 M(+49.0%) | -$22.10 M(-6.9%) |
| June 2020 | - | $9.67 M(-320.1%) | -$23.74 M(-31.8%) |
| Mar 2020 | - | -$4.39 M(-89.5%) | -$34.82 M(+25.1%) |
| Dec 2019 | -$27.82 M(-52.9%) | -$41.79 M(-427.3%) | -$27.82 M(-299.2%) |
| Sept 2019 | - | $12.77 M(-1011.5%) | $13.96 M(+1068.6%) |
| June 2019 | - | -$1.40 M(-154.0%) | $1.20 M(-54.0%) |
| Mar 2019 | - | $2.60 M | $2.60 M |
| Dec 2018 | -$59.04 M(-351.1%) | - | - |
| Dec 2017 | $23.51 M | - | - |
FAQ
- What is Galera Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Galera Therapeutics?
- What is Galera Therapeutics annual CFI year-on-year change?
- What is Galera Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Galera Therapeutics?
- What is Galera Therapeutics quarterly CFI year-on-year change?
- What is Galera Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Galera Therapeutics?
- What is Galera Therapeutics TTM CFI year-on-year change?
What is Galera Therapeutics annual cash flow from investing activities?
The current annual CFI of GRTX is $27.29 M
What is the all time high annual CFI for Galera Therapeutics?
Galera Therapeutics all-time high annual cash flow from investing activities is $36.55 M
What is Galera Therapeutics annual CFI year-on-year change?
Over the past year, GRTX annual cash flow from investing activities has changed by +$3.30 M (+13.75%)
What is Galera Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of GRTX is $0.00
What is the all time high quarterly CFI for Galera Therapeutics?
Galera Therapeutics all-time high quarterly cash flow from investing activities is $19.65 M
What is Galera Therapeutics quarterly CFI year-on-year change?
Over the past year, GRTX quarterly cash flow from investing activities has changed by -$10.46 M (-100.00%)
What is Galera Therapeutics TTM cash flow from investing activities?
The current TTM CFI of GRTX is $14.44 M
What is the all time high TTM CFI for Galera Therapeutics?
Galera Therapeutics all-time high TTM cash flow from investing activities is $59.90 M
What is Galera Therapeutics TTM CFI year-on-year change?
Over the past year, GRTX TTM cash flow from investing activities has changed by -$11.66 M (-44.67%)